Free Trial

Barinthus Biotherapeutics (BRNS) SEC Filings & 10K Form

Barinthus Biotherapeutics logo
$1.04 +0.12 (+12.68%)
(As of 12/18/2024 05:45 PM ET)

Recent Barinthus Biotherapeutics SEC Filings

DateFilerForm TypeView
11/25/2024
3:06 PM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
10:06 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
7:04 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
7:06 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
10:20 AM
Barinthus Biotherapeutics plc. (Subject)
Barinthus Biotherapeutics (Subject)
M&G Plc (Filed by)
Form SC 13G/A
10/15/2024
10:07 AM
Barinthus Biotherapeutics plc. (Subject)
Barinthus Biotherapeutics (Subject)
Cawood Frank Wayne (Filed by)
Form SC 13G
09/05/2024
3:05 PM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:06 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:09 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:15 PM
Barinthus Biotherapeutics plc. (Issuer)
Barinthus Biotherapeutics (Issuer)
Morgon Pierre A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:17 PM
Barinthus Biotherapeutics plc. (Issuer)
Barinthus Biotherapeutics (Issuer)
Hammacher Alex (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:19 PM
Barinthus Biotherapeutics plc. (Issuer)
Barinthus Biotherapeutics (Issuer)
Phillips Anne M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:21 PM
Barinthus Biotherapeutics plc. (Issuer)
Barinthus Biotherapeutics (Issuer)
Scheeren Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:02 PM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K/A
05/13/2024
7:07 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
7:13 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/18/2024
3:15 PM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
7:36 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form DEF 14A
03/22/2024
7:41 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form DEFA14A
03/22/2024
7:43 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form ARS
03/20/2024
4:02 PM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2024
3:25 PM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2024
7:24 AM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
9:17 AM
Barinthus Biotherapeutics plc. (Subject)
Barinthus Biotherapeutics (Subject)
M&G INVESTMENT MANAGEMENT LTD (Filed by)
Form SC 13G/A
01/05/2024
3:15 PM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
7:52 AM
Barinthus Biotherapeutics plc. (Issuer)
Barinthus Biotherapeutics (Issuer)
Brown Gemma (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:54 AM
Barinthus Biotherapeutics plc. (Issuer)
Barinthus Biotherapeutics (Issuer)
Enright William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:55 AM
Barinthus Biotherapeutics plc. (Issuer)
Barinthus Biotherapeutics (Issuer)
Griffiths Graham (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
7:56 AM
Barinthus Biotherapeutics plc. (Issuer)
Barinthus Biotherapeutics (Issuer)
Pelletier Nadege (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
3:01 PM
Barinthus Biotherapeutics plc. (Filer)
Barinthus Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BRNS) was last updated on 12/19/2024 by MarketBeat.com Staff
From Our Partners